-SEC Filing
Related Posts
Recap Of Thursday’s Biotech Catalysts – End Of the Day Summary
The US Food and Drug Administration (FDA) has accepted for filing Krystal Biotech’s (NASDAQ:KRYS) Biologics License Application (BLA)…
Credit Suisse Maintains Neutral on Owens & Minor, Lowers Price Target to $17
Credit Suisse analyst Jonathan Yong maintains Owens & Minor (NYSE:OMI) with a Neutral and lowers the price target from $20 to $17.
Anthem Q2 Medical Enrollment Increased To 1.9M Members
Medical enrollment increased by 1.9 million members year over year and 820 thousand members in the second quarter to 44.3 million members.